Literature DB >> 32458438

Associations of functional, psychosocial, and medical factors with cognitive impairment in older, chemotherapy naïve patients with early breast cancer.

Zev M Nakamura1,2, Allison M Deal2, Kirsten A Nyrop2,3, Emily M Damone4, Hyman B Muss2,3.   

Abstract

Entities:  

Keywords:  cancer; cancer-related cognitive dysfunction; cancer-related cognitive impairment; chemobrain; oncology

Year:  2020        PMID： 32458438      PMCID： PMC7785297          DOI： 10.1002/pon.5433

Source DB:  PubMed          Journal:  Psychooncology        ISSN： 1057-9249            Impact factor:   3.894


× No keyword cloud information.
  10 in total

1.  Four sensitive screening tools to detect cognitive dysfunction in geriatric emergency department patients: brief Alzheimer's Screen, Short Blessed Test, Ottawa 3DY, and the caregiver-completed AD8.

Authors:  Christopher R Carpenter; Elizabeth R Bassett; Grant M Fischer; Jonathan Shirshekan; James E Galvin; John C Morris
Journal:  Acad Emerg Med       Date:  2011-04       Impact factor: 3.451

Review 2.  A review of cognitive screening tools in cancer.

Authors:  Elie Isenberg-Grzeda; Helen Huband; Henry Lam
Journal:  Curr Opin Support Palliat Care       Date:  2017-03       Impact factor: 2.302

3.  Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer.

Authors:  Supriya G Mohile; Allison Magnuson; Chintan Pandya; Carla Velarde; Paul Duberstein; Arti Hurria; Kah Poh Loh; Megan Wells; Sandy Plumb; Nikesha Gilmore; Marie Flannery; Marsha Wittink; Ronald Epstein; Charles E Heckler; Michelle Janelsins; Karen Mustian; Judith O Hopkins; Jane Liu; Srihari Peri; William Dale
Journal:  J Natl Compr Canc Netw       Date:  2018-03       Impact factor: 11.908

4.  Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401.

Authors:  Arti Hurria; Constance T Cirrincione; Hyman B Muss; Alice B Kornblith; William Barry; Andrew S Artz; Linda Schmieder; Rafat Ansari; William P Tew; Douglas Weckstein; Jeffrey Kirshner; Kayo Togawa; Kurt Hansen; Vani Katheria; Richard Stone; Ilene Galinsky; John Postiglione; Harvey Jay Cohen
Journal:  J Clin Oncol       Date:  2011-02-28       Impact factor: 44.544

5.  Associations of functional, psychosocial, medical, and socio-demographic factors with cognitive screening in chemotherapy naïve patients with breast cancer.

Authors:  Zev M Nakamura; Allison M Deal; Kirsten A Nyrop; Seul Ki Choi; William A Wood; Hyman B Muss
Journal:  Psychooncology       Date:  2018-11-08       Impact factor: 3.894

6.  'Chemobrain' in breast carcinoma?: a prologue.

Authors:  Jeffrey S Wefel; Renato Lenzi; Richard Theriault; Aman U Buzdar; Scott Cruickshank; Christina A Meyers
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

7.  Validation of a short Orientation-Memory-Concentration Test of cognitive impairment.

Authors:  R Katzman; T Brown; P Fuld; A Peck; R Schechter; H Schimmel
Journal:  Am J Psychiatry       Date:  1983-06       Impact factor: 18.112

8.  Feasibility of geriatric assessment in community oncology clinics.

Authors:  Grant R Williams; Allison M Deal; Trevor A Jolly; Shani M Alston; Brittaney-Belle E Gordon; Samara A Dixon; Oludamilola A Olajide; W Chris Taylor; Michael J Messino; Hyman B Muss
Journal:  J Geriatr Oncol       Date:  2014-04-03       Impact factor: 3.599

9.  Association between a cognitive screening test and severe chemotherapy toxicity in older adults with cancer.

Authors:  Reena V Jayani; Allison M Magnuson; Can-Lan Sun; Huiyan Ma; William P Tew; Supriya G Mohile; Ajeet Gajra; Heidi D Klepin; Cary P Gross; Hyman B Muss; Andrew E Chapman; Vani Katheria; Arti Hurria; William Dale
Journal:  J Geriatr Oncol       Date:  2019-12-06       Impact factor: 3.599

Review 10.  Cognitive Effects of Cancer and Cancer Treatments.

Authors:  Tim A Ahles; James C Root
Journal:  Annu Rev Clin Psychol       Date:  2018-01-18       Impact factor: 22.098
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.